Skip to content
Screener

Ardelyx ARDX Other Non-Current Assets

Other Non-Current Assets at other companies

Amgen logo
AmgenAMGN
$12.98B+17.7%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$369M-2.9%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$3.87M-24.8%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$54K+350%
XER
Xeris Biopharma Holdings, Inc.XERS
$5.03M-0.7%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$20.1M-8.6%

Other financials

Income statement

See full
Revenue$120.9M+23.8%
Gross profit$115.1M+35.0%
Operating income-$12.4M+13.7%
Net income-$16.7M+12.4%
EPS (diluted)-$0.07+12.5%

Balance sheet

See full
Cash & equivalents$97.2M+7.9%
Total debt$256.2M+24.0%
Total equity$149.0M+6.8%
Total assets$575.9M+23.4%

Cash flow

See full
Operating cash flow-$6.4M+74.7%
CapEx$13.0K-98.0%
Free cash flow-$6.4M+75.3%

Valuation

See full
Market cap$996.75M-23.4%
Enterprise value$1.16B-18.5%
P/S2.2×-1.2×

Profitability

See full
Gross margin94.4%+9.6pp
Operating margin-25.4%
Net margin-12.4%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.7×+0.2×
Current ratio3.3×-1.0×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Ardelyx’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437402-26-000044
Line itemJune 30, 2026December 31, 2025
Inventory, non-current113,127105,372
Prepaid commercial manufacturing, non-current8,494
Right-of-use assets4,0654,795
Other assets6,5016,936
Total assets$575,894$501,604
Liabilities and stockholders’ equity
Current liabilities
Accounts payable$38,410$19,235

Item 1. Financial Statements (Unaudited)

FAQ

What is Ardelyx's other non-current assets?
Ardelyx (ARDX) reported other non-current assets of $6.5M in Q2 2026.
How has Ardelyx's other non-current assets changed year-over-year?
Ardelyx's other non-current assets decreased by 8.0% year-over-year, from $7.07M to $6.5M.
What is the long-term trend for Ardelyx's other non-current assets?
Over 5 years (2020 to 2025), Ardelyx's other non-current assets has grown at a 65.9% compound annual growth rate (CAGR), from $552K to $6.94M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Ardelyx's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude